Clinical Trials Logo

Sleep Disordered Breathing clinical trials

View clinical trials related to Sleep Disordered Breathing.

Filter by:

NCT ID: NCT01179087 Recruiting - Clinical trials for Lung Transplantation

Sleep Disordered Breathing and Lung Transplantation

Start date: August 2010
Phase: N/A
Study type: Observational

The purpose of the study is to investigate the prevalence, clinical predictors and consequences (effect on survival, chronic rejection) of sleep disordered breathing in lung transplant recipients.

NCT ID: NCT00863421 Recruiting - Clinical trials for Chronic Heart Failure

Sleep Disordered Breathing in Patients With Chronic Heart Failure

VISIFA
Start date: September 2008
Phase: N/A
Study type: Observational

Only few prospective studies systematically investigated the prevalence of sleep disordered breathing in patients with stable chronic heart failure. Furthermore there is no report on the incidence rate of sleep disordered breathing in this population. This is a prospective multi-centre study of sleep-disordered breathing in 200 patients with stable moderate-to-severe chronic heart failure. Eligible patients will undergo overnight full-night polysomnography, lung function testing, laboratory measurements, and hemodynamic recordings. Measurements will be repeated at 6 months interval for a follow-up period of two years irrespective of the presence or absence of sleep disordered breathing. The primary outcome variable for this study is the prevalence of sleep disordered breathing in the study population. Secondary outcome variables include the 2-year incidence rate of sleep disordered breathing, quality of life measurements, exercise capacity, sleep quality, hemodynamic measurements, and laboratory markers of neurohumoral activation, systemic inflammation, and endothelial function in the study population.

NCT ID: NCT00299910 Recruiting - Clinical trials for Sleep Disordered Breathing

Inflammatory Response to Anti Inflammatory Therapy in Children With Sleep Disordered Breathing

Start date: March 2005
Phase: Phase 4
Study type: Interventional

This study will assess in a double blind placebo controlled fashion the effects of a 12 week course of oral montelukast/placebo on polysomnographic and radiological findings and will characterize the systemic (serum,urine) and local (upper airway collected biological samples) inflammatory response in children (2-10 years of age) with sleep disordered breathing, fittingthe inclusion and exclusion criteria.